ClinicalTrials.Veeva

Menu

Left Atrium Substrate Based Ablation Plus Circumferential Pulmonary Vein Isolation to Treat Chronic Atrial Fibrillation

N

Nanjing Medical University

Status

Unknown

Conditions

Atrial Fibrillation

Treatments

Procedure: radiofrequency catheter ablation

Study type

Interventional

Funder types

Other

Identifiers

NCT01716143
2011-SR-014

Details and patient eligibility

About

The purpose of this study is to determine whether left atrium substrate based ablation plus circumferential is effective in the treatment of persistent and long-standing atrial fibrillation.

Enrollment

87 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

All persistent or permanent AF patients with refractory or intolerant to at least one Class 1 or Class 3 antiarrhythmic medication.

Exclusion criteria

  1. Patients with paroxysmal AF (self-terminating episodes lasting < 7 day)
  2. Patients who have had a previous AF ablation procedure
  3. Pregnancy

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

87 participants in 1 patient group

catheter ablation
Other group
Treatment:
Procedure: radiofrequency catheter ablation

Trial contacts and locations

1

Loading...

Central trial contact

Minglong Chen, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems